Worth Venture Partners »

Verona Pharma shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Verona Pharma shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Verona Pharma

Tip: Access up to 7 years of quarterly data

All positions including Verona Pharma held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verona Pharma by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.7k 15k 0.38

More positions owned by Worth Venture Partners

Bloomin Brands Note 5.000% 5/0 (Principal)
Livent Corp Note 4.125% 7/1 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Myomo Com New (MYO)
Aspen Aerogels (ASPN)
Chart Inds Note 1.000%11/1 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Scpharmaceuticals (SCPH)
Indie Semiconductor Class A Com (INDI)
Veradigm Note 0.875% 1/0 (Principal)
Transphorm (TGAN)
Transocean Deb 4.625% 9/3 (Principal)
Sarepta Therapeutics DBCV 1.500%11/1 (Principal)
Ouster Com New (OUST)
Geo Corrections Holdings Note 6.500% 2/2 (Principal)

View all positions for Worth Venture Partners

Top funds holding Verona Pharma

Simplex Trading
Worth Venture Partners
Jane Street

View all funds holding Verona Pharma